Cargando…
355. A Novel Likelihood-Based Model to Estimate SARS-CoV-2 Viral Titer from Next-Generation Sequencing Data
BACKGROUND: The quantitative level of pathogens present in a host is a major driver of infectious disease (ID) state and outcome. However, the majority of ID diagnostics are qualitative. Next-generation sequencing (NGS) is an emerging ID diagnostics and research tool to provide insights, including t...
Autores principales: | Wells, Heather L, Barrows, Joseph, Couto-Rodriguez, Mara, Jirau Serrano, Xavier O, Debieu, Marilyne, Wessel, Karen, Jonsson, Colleen B, Connor, Bradley A, Mason, Christopher, Nagy-Szakal, Dorottya, O’Hara, Niamh B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690726/ http://dx.doi.org/10.1093/ofid/ofab466.556 |
Ejemplares similares
-
423. SARS-CoV-2 NGS Assay Powered by Biotia COVID-DX Software
por: Nagy-Szakal, Dorottya, et al.
Publicado: (2020) -
Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights
por: Nagy-Szakal, Dorottya, et al.
Publicado: (2021) -
368. Performance Characteristics of Sequencing Assays for Identification of the SARS-CoV-2 Viral Genome
por: Antaki, Danny, et al.
Publicado: (2021) -
Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case
por: Connor, Bradley A, et al.
Publicado: (2021) -
149. Extraction-free RT-PCR to Detect SARS-CoV-2 Variants of Concern
por: Harry, Brian L, et al.
Publicado: (2021)